CEF9, Influenza Virus M1 128-135 is a matrix protein fragment frequently used to evaluate viral epitope presentation. Its sequence properties aid exploration of peptide stability and processing pathways. Researchers use it to investigate immune recognition of structural viral components. The peptide supports broad analyses of conserved influenza epitopes.
CAT No: C14009
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More